Skip to main content
. 2019 Oct 24;13(1):116–124. doi: 10.1111/cts.12692

Figure 3.

Figure 3

Comparison of the Clinical Pharmacogenetics Implementation Consortium method and percentage activity method for translating CYP2D6 genotype to phenotype. Thin lines represent different ways to translate activity score (AS) into phenotype and the bold lines represent the recommended CYP2D6 genotype to phenotype translation consensus system. IM, intermediate metabolizer; NM, normal metabolizer; PM, poor metabolizer; UM, ultrarapid metabolizer.